AOD-9604 10mg

What is AOD 9604? AOD 9604 is a research peptide derived from the C-terminal fragment of human growth hormone (HGH). Unlike full-length HGH, AOD 9604 was designed to specifically target fat metabolism without stimulating growth-related pathways. Researchers are studying its potential role in weight management, metabolic health, and joint recovery. How AOD 9604 Works AOD 9604 acts directly on fat metabolism rather than growth or cell division. It works through three main mechanisms: Stimulates lipolysis – promotes the breakdown of stored fat. Inhibits lipogenesis – helps prevent the formation of new fat cells. Enhances fat oxidation – encourages the body to burn fat as energy. Unlike HGH, AOD 9604 does not raise IGF-1 levels, making it a safer research candidate with fewer risks of unwanted side effects.

AOD-9604 works by selectively targeting fat cells and triggering the breakdown of stored fat while preventing the formation of new fat cells. This process, known as lipolysis, is enhanced without affecting blood sugar or muscle protein synthesis. AOD-9604 is also thought to increase beta-3 adrenergic receptors in adipose tissue, which are responsible for fat burning, especially in stubborn areas such as the abdomen, thighs, and hips.

AOD-9604 has been approved in certain countries for use in clinical research and has received regulatory approval in Australia as a listed ingredient in products. However, it has not been approved by the FDA for medical use in the United States and is typically available through peptide suppliers for research purposes. Because of its association with fat loss and metabolism, AOD-9604 is sometimes used off-label by fitness enthusiasts and bodybuilders, despite the lack of formal approval.